Evidence map›Paper›PMID 20454966›Full record

ReviewWorld journal of urology2010

Photodynamic therapy for focal ablation of the prostate.

Nimalan Arumainayagam, C M Moore, Hashim U Ahmed, M Emberton

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Cellular Mechanisms of Singlet Oxygen in Photodynamic Therapy.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Robotic System for MRI-guided Focal Laser Ablation in the Prostate.IEEE/ASME transactions on mechatronics : a joint publication of the IEEE Industrial Electronics Society and the ASME Dynamic Systems and Control Division · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Focal therapy for prostate cancer - where are we in 2011?Therapeutic advances in urology · 2011
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nimalan ArumainayagamDivision of Surgery and Interventional Sciences, National Medical Laser Centre, University College London, Charles Bell House, 67-73 Riding House Street, London W1W 7EJ, UK. nim.arum@ucl.ac.uk
C M Moore
Hashim U Ahmed
M Emberton
University College London · GBUK Health Forum · GB

Funding

Medical Research Council G0701302Medical Research Council G1002509
6 · The paper itself

Abstract

Although in early stages of clinical development, photodynamic therapy (PDT) shows promise in delivering focal treatment of both primary and post-radiotherapy prostate cancer. This article will review the mechanism of action of PDT, previous research using PDT for treating prostate cancer including the development of newer vascular-acting photosensitizers, and the potential advantages and disadvantages of PDT in delivering focal therapy.

Indexed as

PhotochemotherapyDihematoporphyrin EtherHumansMaleMesoporphyrinsMetalloporphyrinsPhotosensitizing AgentsProstatic NeoplasmsTreatment OutcomeDihematoporphyrin EtherMesoporphyrinsMetalloporphyrinsmotexafin lutetiumPhotosensitizing Agentstemoporfin

Identifiers

PMID20454966
OpenAlexW1995830749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.